Cargando…

The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator

Ischemic stroke is a leading cause of disability and mortality worldwide. The only approved treatment for ischemic stroke is thrombolytic therapy with tissue plasminogen activator (tPA), though this approach often leads to a severe complication: hemorrhagic transformation (HT). The pathophysiology o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babenko, Valentina A., Fedulova, Ksenia S., Silachev, Denis N., Rahimi-Moghaddam, Parvaneh, Kalyuzhnaya, Yulia N., Demyanenko, Svetlana V., Plotnikov, Egor Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381732/ https://www.ncbi.nlm.nih.gov/pubmed/37511788 http://dx.doi.org/10.3390/jpm13071175

Ejemplares similares

Human Multipotent Mesenchymal Stromal Cell–Derived Extracellular Vesicles Enhance Neuroregeneration in a Rat Model of Sciatic Nerve Crush Injury
por: Demyanenko, Svetlana V., et al.
Publicado: (2022)

Noncoupled Mitochondrial Respiration as Therapeutic Approach for the Treatment of Metabolic Diseases: Focus on Transgenic Animal Models
por: Gureev, Artem P., et al.
Publicado: (2023)

Miro1 Enhances Mitochondria Transfer from Multipotent Mesenchymal Stem Cells (MMSC) to Neural Cells and Improves the Efficacy of Cell Recovery
por: Babenko, Valentina A., et al.
Publicado: (2018)

Identification of Metabolomic Signatures for Ischemic Hypoxic Encephalopathy Using a Neonatal Rat Model
por: Shevtsova, Yulia, et al.
Publicado: (2023)

Matrix Metalloproteinase-9 Relationship With Infarct Growth and Hemorrhagic Transformation in the Era of Thrombectomy
por: Mechtouff, Laura, et al.
Publicado: (2020)

Mitochondria as a Source and a Target for Uremic Toxins
por: Popkov, Vasily A., et al.
Publicado: (2019)

Kidney Cells Regeneration: Dedifferentiation of Tubular Epithelium, Resident Stem Cells and Possible Niches for Renal Progenitors
por: Andrianova, Nadezda V., et al.
Publicado: (2019)

Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer
por: Kim, Tae-Dong, et al.
Publicado: (2006)

Development of an In Vitro Model of SARS-CoV-Induced Acute Lung Injury for Studying New Therapeutic Approaches
por: Shevtsova, Yulia A., et al.
Publicado: (2022)

Neuroprotective Potential of Mild Uncoupling in Mitochondria. Pros and Cons
por: Zorov, Dmitry B., et al.
Publicado: (2021)

Correlation between the −1562C/T polymorphism in the matrix metalloproteinase-9 gene and hemorrhagic transformation of ischemic stroke
por: ZHANG, XIAOMAN, et al.
Publicado: (2015)

Lessons from the Discovery of Mitochondrial Fragmentation (Fission): A Review and Update
por: Zorov, Dmitry B., et al.
Publicado: (2019)

Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen
por: Brauer, Rena, et al.
Publicado: (2011)

Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations☆
por: Di, Fei, et al.
Publicado: (2012)

Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis
por: Tveita, Anders, et al.
Publicado: (2008)

Matrix Metalloproteinases in Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage
por: Mehta, Vivek, et al.
Publicado: (2013)

Extracellular matrix metalloproteinase inducer in brain ischemia and intracerebral hemorrhage
por: Liu, Yang, et al.
Publicado: (2022)

Age-Related Changes in Bone-Marrow Mesenchymal Stem Cells
por: Babenko, Valentina A., et al.
Publicado: (2021)

Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity
por: Morgan, Hayley, et al.
Publicado: (2005)

The Mitochondria-Targeted Antioxidants and Remote Kidney Preconditioning Ameliorate Brain Damage through Kidney-to-Brain Cross-Talk
por: Silachev, Denis N., et al.
Publicado: (2012)

The Mechanisms Underlying the Protective Action of Selenium Nanoparticles against Ischemia/Reoxygenation Are Mediated by the Activation of the Ca(2+) Signaling System of Astrocytes and Reactive Astrogliosis
por: Varlamova, Elena G., et al.
Publicado: (2021)

Is the Mitochondrial Membrane Potential (∆Ψ) Correctly Assessed? Intracellular and Intramitochondrial Modifications of the ∆Ψ Probe, Rhodamine 123
por: Zorova, Ljubava D., et al.
Publicado: (2022)

(±)Equol inhibits invasion in prostate cancer DU145 cells possibly via down-regulation of matrix metalloproteinase-9, matrix metalloproteinase-2 and urokinase-type plasminogen activator by antioxidant activity
por: Zheng, Wei, et al.
Publicado: (2012)

Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration
por: Zhuang, Thompson, et al.
Publicado: (2013)

Mechanisms of LPS-Induced Acute Kidney Injury in Neonatal and Adult Rats
por: Plotnikov, Egor Y., et al.
Publicado: (2018)

Mechanisms of Age-Dependent Loss of Dietary Restriction Protective Effects in Acute Kidney Injury
por: Andrianova, Nadezda V., et al.
Publicado: (2018)

Matrix Metalloproteinases and Glaucoma Treatment
por: Weinreb, Robert N., et al.
Publicado: (2020)

Differential Regulation of Matrix-Metalloproteinases and Their Tissue Inhibitors in Patients with Aneurysmal Subarachnoid Hemorrhage
por: Fischer, Marlene, et al.
Publicado: (2013)

Mesenchymal stromal cell-derived extracellular vesicles afford neuroprotection by modulating PI3K/AKT pathway and calcium oscillations
por: Turovsky, Egor A., et al.
Publicado: (2022)

Resemblance and differences in dietary restriction nephroprotective mechanisms in young and old rats
por: Andrianova, Nadezda V., et al.
Publicado: (2020)

Age-Associated Loss in Renal Nestin-Positive Progenitor Cells
por: Buyan, Marina I., et al.
Publicado: (2022)

Pregnancy protects the kidney from acute ischemic injury
por: Popkov, Vasily A., et al.
Publicado: (2018)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and transforming growth factor beta 1 in the aqueous humor and serum of patients with pseudoexfoliation syndrome
por: Kara, Selcuk, et al.
Publicado: (2014)

Expression of Amyloid Precursor Protein, Caveolin-1, Alpha-, Beta-, and Gamma-Secretases in Penumbra Cells after Photothrombotic Stroke and Evaluation of Neuroprotective Effect of Secretase and Caveolin-1 Inhibitors
por: Sharifulina, Svetlana, et al.
Publicado: (2022)

Matrix metalloproteinases, tissue inhibitor of metalloproteinase and transforming growth factor A1 in the remodeling of chronic rhinosinusitis in North China
por: Wang, XiangDong, et al.
Publicado: (2013)

Variants in matrix metalloproteinase‐9 gene are associated with hemorrhagic transformation in acute ischemic stroke patients with atherothrombosis, small artery disease, and cardioembolic stroke
por: Yi, Xingyang, et al.
Publicado: (2019)

Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke
por: Kanazawa, Masato, et al.
Publicado: (2017)

Receptor-independent Role of Urokinase-Type Plasminogen Activator in Pericellular Plasmin and Matrix Metalloproteinase Proteolysis during Vascular Wound Healing in Mice
por: Carmeliet, Peter, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_qdjf606opemj6k63lrnsf5nb9t